Horizon Therapeutics PLC
NASDAQ:HZNP
Horizon Therapeutics PLC
Net Income (Common)
Horizon Therapeutics PLC
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Horizon Therapeutics PLC
NASDAQ:HZNP
|
Net Income (Common)
$438m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Alkermes Plc
NASDAQ:ALKS
|
Net Income (Common)
$355.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
33%
|
|
Amarin Corporation PLC
NASDAQ:AMRN
|
Net Income (Common)
-$52.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
15%
|
CAGR 10-Years
9%
|
|
Prothena Corporation PLC
NASDAQ:PRTA
|
Net Income (Common)
-$147m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-14%
|
|
M
|
Mural Oncology PLC
NASDAQ:MURA
|
Net Income (Common)
-$207.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Horizon Therapeutics PLC's Net Income (Common)?
Net Income (Common)
438m
USD
Based on the financial report for Jun 30, 2023, Horizon Therapeutics PLC's Net Income (Common) amounts to 438m USD.
What is Horizon Therapeutics PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
-5%
Over the last year, the Net Income (Common) growth was -43%. The average annual Net Income (Common) growth rates for Horizon Therapeutics PLC have been -5% over the past three years .